Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome
- 1 May 2002
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 61 (5), 1769-1775
- https://doi.org/10.1046/j.1523-1755.2002.00319.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The ACAT Inhibitor Avasimibe Reduces Macrophages and Matrix Metalloproteinase Expression in Atherosclerotic Lesions of Hypercholesterolemic RabbitsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Acyl-coenzyme A: Cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7?-hydroxylase in cultured rat hepatocytes andin vivo in the ratHepatology, 1999
- New insights into lipid metabolism in the nephrotic syndromeKidney International, 1999
- Identification of a Form of Acyl-CoA:Cholesterol Acyltransferase Specific to Liver and Intestine in Nonhuman PrimatesJournal of Biological Chemistry, 1998
- Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesisKidney International, 1998
- ACYL-COENZYME A:CHOLESTEROL ACYLTRANSFERASEAnnual Review of Biochemistry, 1997
- Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Bile acid biosynthesisBiochemistry, 1992
- Regulation of acylcoenzyme A. Cholesterol acyltransferase and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by lipoproteins in the intestine of parabiont rats.JCI Insight, 1984
- The Low-Density Lipoprotein Pathway and its Relation to AtherosclerosisAnnual Review of Biochemistry, 1977